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1343 Experimental study of extracorporeal lung resection in dogs: Ex situ sleeve
resection and autotransplantation of the pulmonary lobe after extended
pneumonectomy for central lung cancer
Isao Matsumoto, MD, Makoto Oda, MD, Yoshio Tsunezuka, MD, Masaya Tamura, MD,
Kazuyuki Kawakami, MD, and Go Watanabe, MD, Kanazawa, Japan
The aim of this study was to investigate whether extracorporeal lung resection (ECLR) for lung
cancer can be performed safely. The extensive lymph node dissection had severe adverse
effects on bronchial anastomotic healing in ECLR. Therefore ECLR can be applied to only a
very limited number of patients with N0 or N1 disease.
1350 Safety and efficacy of median sternotomy versus video-assisted thoracic
surgery for lung volume reduction surgery
National Emphysema Treatment Trial Research Group
This article compares the results of LVRS by median sternotomy (MS) or VATS in the
National Emphysema Treatment Trial. Morbidity and mortality were low and similar for both
groups. Recovery was more rapid and less costly for VATS than MS. Functional results were
comparable.
1361 Surgical management of childhood bronchiectasis due to infectious disease
Gokhan Haciibrahimoglu, MD, Mithat Fazlioglu, MD, Aysun Olcmen, MD, Atilla Gurses, MD,
and Mehmet Ali Bedirhan, MD, Istanbul, Turkey
The purpose of this study was to evaluate patients undergoing resection for childhood
bronchiectasis. Surgery for this can be performed with low mortality and morbidity. Complete
resection should be performed when possible.
1366 Cost-effectiveness of pulmonary resection and systemic chemotherapy in the
management of metastatic soft tissue sarcoma: A combined analysis from
the University of Texas M. D. Anderson and Memorial Sloan-Kettering
Cancer Centers
Geoffrey A. Porter, MD, Scott B. Cantor, PhD, Garrett L. Walsh, MD, Valerie W. Rusch, MD,
Dennis H. Leung, PhD, Alma Y. DeJesus, MSN, Raphael E. Pollock, MD, PhD,
Murray F. Brennan, MD, and Peter W. T. Pisters, MD, Halifax, Nova Scotia, Canada;
Houston, Tex; New York, NY; and Singapore
This cost-effectiveness study examined the use of surgery, systemic chemotherapy, or both, in
the management of pulmonary metastases from soft tissue sarcoma. Pulmonary resection was
the most cost-effective treatment strategy examined.
Surgery for Acquired
Cardiovascular Disease
(ACD)
1373 Should the transverse aortic arch be replaced simultaneously with aortic
root replacement for annuloaortic ectasia in Marfan syndrome?
Osamu Tagusari, MD, Hitoshi Ogino, MD, Junjiro Kobayashi, MD, Ko Bando, MD,
Kenji Minatoya, MD Hiroaki Sasaki, MD, Kazuo Niwaya, MD, Yutaka Okita, MD,
Motomi Ando, MD, Toshikatu Yagihara, MD, and Soichiro Kitamura, MD, Osaka, Hyogo,
and Aichi, Japan
In a retrospective study of patients with Marfan syndrome, the incidence of new dissection in
the residual intact arch after aortic root replacement was extremely low. Prophylactic
replacement of the intact arch is therefore not necessary at aortic root replacement for
annuloaortic ectasia.
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